- Threats of tariffs and restrictive pricing policies involving major companies like Johnson & Johnson, Eli Lilly, and Roche, alongside Congressional planning.
- Tax law provided certainty amid tariff uncertainty on August 5, 2025.
Johnson & Johnson voluntarily listed drugs for tariff exemption and announced the expansion of its prescription drug website.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Johnson & Johnson voluntarily listed drugs for tariff exemption and announced the expansion of its prescription drug website.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)